Minirin Description

Tablet: MINIRIN 0.1 mg: Each tablet contains desmopressin acetate 0.1 mg equivalent to desmopressin (free base) 0.089 mg.
The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.
Oral lyophilisate: Each melt oral lyophilisate contains desmopressin (free base) 60 mcg and 120 mcg added as desmopressin acetate, respectively.
Injection: 1 ml MINIRIN solution for injection contains 4 microgram desmopressin acetate equivalent to 3.56 microgram desmopressin.
Excipients with known effect: This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially sodium-free.
Nasal spray: Each mL of solution for nasal spray contains desmopressin acetate 0.1 mg equivalent to 89 μg desmopressin and, benzalkonium chloride 0.1 mg.
Minirin nasal spray is supplied in bottles provided with precompression spray pumps designed to deliver 10 mcg per spray dose.
Excipients/Inactive Ingredients: Tablet: lactose monohydrate, potato starch, povidone and magnesium stearate.
Oral lyophilisate: Gelatin, mannitol (E421) and anhydrous citric acid.
Injection: Sodium chloride, hydrochloric acid and water for injection.
Nasal spray: Benzalkonium chloride (solution), sodium chloride, citric acid monohydrate (E 330), disodium phosphate dihydrate, and purified water.